Houston, TX - August 07, 2012
Dow Performance Packaging, a business unit of The Dow Chemical Company (NYSE: DOW), and MuCell Extrusion LLC announced that MuCell will exclusively license Dow’s Thin Foamed Films Patent family, using MuCell’s innovative Foaming technology to create physically foamed films for all film applications. This contract will further the two companies’ relationship as innovation collaborators.
The agreement not only eliminates existing confusion among potential customers as to patent and licensing obligations, but it also provides a clear demarcation of responsibilities for support of these foaming technologies. Dow will continue to offer resins specially formulated to optimize foaming results while MuCell will provide hands-on technology transfer equipment and technical support to customers.
“Dow has a great business relationship with MuCell and we look forward to creating the new portfolio together,” said Greg Bunker, Associate Marketing Director at Dow. “Foaming films is an excellent route to more sustainable packaging by reducing the usage of resin by 10-20 percent. Through this agreement, both companies are demonstrating their commitment to create superior foamed products that have less impact on the environment. The results will help our customers address their sustainability platforms and develop low environmental impact technology.”
This agreement follows from a similar strategic agreement from earlier this year, wherein Dow and MuCell Extrusion LLC reached an agreement for MuCell Extrusion to exclusively license Dow’s patent family on flat sheet resin technology.
“We provide expertise in process development and equipment packages necessary to implement the technology, and Dow offers formulation expertise in resins to streamline the process. This agreement not only marries two steps in the value chain, supply and processing, but that all of the relevant intellectual property for both film and flat sheet resin technology has now been bundled into one source,” said Mark Lindenfelzer, president of MuCell Extrusion LLC. “We have no doubt that this will be a successful venture for MuCell, Dow and our clients.”
Dow (NYSE: DOW) combines the power of science and technology to passionately innovate what is essential to human progress. The Company connects chemistry and innovation with the principles of sustainability to help address many of the world's most challenging problems such as the need for clean water, renewable energy generation and conservation, and increasing agricultural productivity. Dow's diversified industry-leading portfolio of specialty chemical, advanced materials, agrosciences and plastics businesses delivers a broad range of technology-based products and solutions to customers in approximately 160 countries and in high growth sectors such as electronics, water, energy, coatings and agriculture. In 2012, Dow had annual sales of approximately $57 billion and employed approximately 54,000 people worldwide. The Company's more than 5,000 products are manufactured at 188 sites in 36 countries across the globe. References to "Dow" or the "Company" mean The Dow Chemical Company and its consolidated subsidiaries unless otherwise expressly noted. More information about Dow can be found at www.dow.com.
About MuCell Extrusion
MuCell Extrusion LLC, based in Woburn, MA, USA licenses technology for use in plastic extrusion processes. Used in rigid sheet, low density flexible sheet, film, pipe/tubing, and blow moulding as well as custom solutions, MuCell® microcellular foaming technology reduces weight and polymer content of plastic extrusions and/or creates light density foamed solutions using environmentally friendly gases. MuCell Extrusion LLC is 100% owned by Zotefoams plc.
For Editorial Information:
The Dow Chemical Company
Gibbs & Soell
+1 312-648-6700 x 2101
MuCell Extrusion LLC